At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 100 enrolled
Drug / intervention
Bioresorbable vascular scaffold +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Bioresorbable Vascular Scaffold in Patient With ST Elevation Myocardial Infarction: a Randomized Comparison With Everolimus Eluting Stent
In Brief
A Phase 4 clinical trial evaluating Bioresorbable vascular scaffold and Everolimus eluting stent for ST Elevation Acute Myocardial Infarction. Completed, enrolled 100 participants across 1 site.
Detailed Summary
Evaluation of the feasibility and safety of Bioresorbable Vascular Scaffold (BVS) in patient treated with primary PCI (pPCI).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsST Elevation Acute Myocardial Infarction
CountriesItaly
Collaborators--
Timeline
Phase 4CompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartMay 2013
Primary CompletionAug 2013
Study CompletionApr 2014
First PostedJun 2014
TodayJul 2026
First PostedJun 2, 2014
Enrollment StartMay 1, 2013
Primary CompletionAug 1, 2013
Study CompletionApr 1, 2014
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 12.1 years ago
Interventions
Bioresorbable vascular scaffolddevice
stenting of an acute thrombotic lesion in patient within STEMI
Everolimus eluting stentdevice
stenting of an acute thrombotic lesion in patient within STEMI